- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04312776
Tracing MRSA in Households With Patients Infected With CA-MRSA by WGS
Study Overview
Detailed Description
Eligibility criteria:
- Inclusion criteria: Patients (Child, Adult) with infections caused by S. aureus from the sites as follows: blood stream, skin or soft tissue, cerebrospinal fluid, bone and joint, genitourinary tract, infection of indwelling intravascular device, surgical wound, respiratory tract (organism grown from sputum and infiltrate on chest X-ray), peritoneal fluid or other otherwise sterile body fluids.
- Exclusion criteria: Patients with risk factors for nosocomial or medically related infections, and patients who have been decolonized (using mupirocin, chlorhexidine or bleach) in the past month.
Outcome measures:
- Isolation rate of staphylococcus aureus and methicillin-resistant staphylococcus aureus on domestic environment, contact and pets and livestock.
- Molecular characteristics of CA-MRSA isolates recovered in Chinese hospitals, home environments, contacts, and pets and livestock.
Definition:
A MRSA infection was considered to be HA-MRSA by the CDC epidemiologic definitions if, in the year prior to culture, the subject had surgery, hospitalization, hemodialysis or a stay in a long-term care facility, if an indwelling vascular catheter was in place at the time of culture, or if the subject was an inpatient hospitalized for 2 days at the time of culture. Otherwise, the subject was considered to have a CA-MRSA infection.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Zhejiang
-
Hanzhou, Zhejiang, China, 310016
- Sir Run Run Shaw Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients (Adult) with infections caused by S. aureus from the sites as follows: blood stream, skin or soft tissue, cerebrospinal fluid, bone and joint, genitourinary tract, infection of indwelling intravascular device, surgical wound, respiratory tract (organism grown from sputum and infiltrate on chest X-ray), peritoneal fluid or other otherwise sterile body fluids.
Exclusion Criteria:
- Patients with risk factors for nosocomial or medically related infections, and patients who have been decolonized (using mupirocin, chlorhexidine or bleach) in the past month.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Patients infected with CA-MRSA
It is an observational study, no interventions to any of the two study arms.
|
|
Healthy people without any infection
It is an observational study, no interventions to any of the two study arms.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Clonal Distribution of CA-MRSA in China The distribution of sequence types in CA-MRSA isolates from China
Time Frame: During the study period (One years)
|
During the study period (One years)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Yun-song Yu, MD, Sir Run Run Shaw Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- SRRSH-Household01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on MRSA
-
Hvidovre University HospitalRecruiting
-
Indiana UniversityWithdrawnHospital Acquired MRSA | Community Acquired MRSAUnited States
-
Johns Hopkins UniversityRobert Wood Johnson FoundationCompleted
-
Leiden University Medical CenterRecruiting
-
Indiana UniversityUnknown
-
Enanta Pharmaceuticals, IncCompleted
-
Heidelberg UniversityCompleted
-
Nantes University HospitalNot yet recruiting
-
NYU Langone HealthCompleted
Clinical Trials on none intervention
-
University of Campania "Luigi Vanvitelli"CompletedBirth Weight | Systemic Inflammation Markers | Combined Systemic Inflammatory IndicesItaly
-
University of GiessenCompleted
-
Peking University First HospitalActive, not recruitingSARS-CoV-2 Infection | Hematologic MalignancyChina
-
Acibadem UniversityCompleted
-
Acibadem UniversityCompleted
-
Universidad Católica del MauleFondo Nacional de Desarrollo Científico y Tecnológico, ChileCompletedMental Disorders | Suicide, AttemptedChile
-
Shanghai Mental Health CenterUnknownSchizophrenia | ViolenceChina
-
Sir Run Run Shaw HospitalUnknown
-
Azienda Ospedaliero Universitaria Maggiore della...CompletedChronic Kidney Diseases
-
Fondazione Policlinico Universitario Agostino Gemelli...CompletedCarbapenem | Klebsiella Pneumonia